Morning Briefing
Summaries of health policy coverage from major news organizations
Maker Of Experimental Ebola Drug Scales Up
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
